Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
ZYGOMED from Anderlecht, company number BE1002030289, closed financial year 2024 with a result of € 110,128 after tax. For that financial year ZYGOMED recorded a gross margin of € 162,680 and equity of € 113,295. Compared with financial year 2023, the result moved from € 287 to € 110,128. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2025.
€ 113,295
▲ € 109,295 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 110,128
▲ € 109,841 vs 2023
Profit after tax over the fiscal year.
€ 163,270
▲ € 161,487 vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 14,604
▼ 30% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 1,422
▼ 41% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 36,311
▲ € 35,566 vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Gross margin | € 2,942 | € 162,680 | ▲ € 159,738 |
| Profit after taxes | € 287 | € 110,128 | ▲ € 109,841 |
| Equity | € 4,000 | € 113,295 | ▲ € 109,295 |
| Total debts | € 50,589 | € 87,236 | ▲ 72% |
| Cash | € 1,782 | € 163,270 | ▲ € 161,487 |
| Retained profit | € 0 | € 109,295 | |
| Dividend | € 287 | € 833 | ▲ 190% |
| Balance sheet total | € 54,589 | € 200,531 | ▲ 267% |
Key figures of ZYGOMED, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to ZYGOMED?
What happened at ZYGOMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2024. filed late Source: NBB ↗
- New establishment in Anderlecht. KBO
- Firas Shall became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 287 profit in 2023 to € 110,128 profit in 2024.
Paid € 35,727 in corporate taxes since 2023.
Best year ever: 2024, with € 110,128 profit.
Paid out € 1,120 in dividends to the owners in total.
A new publication or filing at ZYGOMED? We notify you, reason included.
Follow ZYGOMEDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
Firas Shall
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Denis Verdonckstraat 16 box 2.01
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1002.030.289
- VAT number
- BE 1002.030.289
- Registered office
- Denis Verdonckstraat 16 bus 2.01, 1070 Anderlecht
- Names & denominations
- ZYGOMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 November 2023
- Peppol
- Not registered
- Activities · NACE
Activiteiten op het gebied van mondzorg, muv activiteiten van tandartspraktijken